Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NovaDigm Therapeutics Announces Initiation of Phase 2a Clinical Trial of NDV-3A in Staphylococcus aureus

biospaceApril 20, 2018

Tag: NovaDigm Therapeutics , NovaDigm Therapeutics宣布启动NDV-3A在金黄色葡萄球菌中的2a期临床试验

PharmaSources Customer Service